175 related articles for article (PubMed ID: 17216219)
1. Tumor budding as a prognostic marker in stage-III rectal carcinoma.
Choi HJ; Park KJ; Shin JS; Roh MS; Kwon HC; Lee HS
Int J Colorectal Dis; 2007 Aug; 22(8):863-8. PubMed ID: 17216219
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of tumor budding in patients who had surgery for rectal cancer with and without neoadjuvant therapy.
Şirin AH; Sökmen S; Ünlü SM; Ellidokuz H; Sarioğlu S
Tech Coloproctol; 2019 Apr; 23(4):333-342. PubMed ID: 30900039
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of tumor budding in rectal cancer biopsies before neoadjuvant therapy.
Rogers AC; Gibbons D; Hanly AM; Hyland JM; O'Connell PR; Winter DC; Sheahan K
Mod Pathol; 2014 Jan; 27(1):156-62. PubMed ID: 23887296
[TBL] [Abstract][Full Text] [Related]
4. Intensity of tumor budding and its prognostic implications in invasive colon carcinoma.
Park KJ; Choi HJ; Roh MS; Kwon HC; Kim C
Dis Colon Rectum; 2005 Aug; 48(8):1597-602. PubMed ID: 15937624
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of preoperative carcinoembryonic antigen/tumor size in rectal cancer.
Cai D; Huang ZH; Yu HC; Wang XL; Bai LL; Tang GN; Peng SY; Li YJ; Huang MJ; Cao GW; Wang JP; Luo YX
World J Gastroenterol; 2019 Sep; 25(33):4945-4958. PubMed ID: 31543685
[TBL] [Abstract][Full Text] [Related]
6. The potential predictive value of tumor budding for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer.
Jäger T; Neureiter D; Fallaha M; Schredl P; Kiesslich T; Urbas R; Klieser E; Holzinger J; Sedlmayer F; Emmanuel K; Dinnewitzer A
Strahlenther Onkol; 2018 Nov; 194(11):991-1006. PubMed ID: 30069738
[TBL] [Abstract][Full Text] [Related]
7. Intensity of tumor budding as an index for the malignant potential in invasive rectal carcinoma.
Ha SS; Choi HJ; Park KJ; Kim JM; Kim SH; Roh YH; Kwon HC; Roh MS
Cancer Res Treat; 2005 Jun; 37(3):177-82. PubMed ID: 19956500
[TBL] [Abstract][Full Text] [Related]
8. Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer.
Ueno H; Murphy J; Jass JR; Mochizuki H; Talbot IC
Histopathology; 2002 Feb; 40(2):127-32. PubMed ID: 11952856
[TBL] [Abstract][Full Text] [Related]
9. Pathological prognostic factors in locally advanced rectal carcinoma after neoadjuvant radiochemotherapy: analysis of 113 cases.
Sannier A; Lefèvre JH; Panis Y; Cazals-Hatem D; Bedossa P; Guedj N
Histopathology; 2014 Nov; 65(5):623-30. PubMed ID: 24701980
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of the mesorectal extension of rectal cancer: a Japanese multi-institutional study.
Shirouzu K; Akagi Y; Fujita S; Ueno H; Takii Y; Komori K; Ito M; Sugihara K;
Ann Surg; 2011 Apr; 253(4):704-10. PubMed ID: 21475010
[TBL] [Abstract][Full Text] [Related]
11. Morphology and prognostic value of tumor budding in rectal cancer after neoadjuvant radiotherapy.
Du C; Xue W; Li J; Cai Y; Gu J
Hum Pathol; 2012 Jul; 43(7):1061-7. PubMed ID: 22204710
[TBL] [Abstract][Full Text] [Related]
12. [Prognostic value of lymph node ratio staging system in stage III( rectal cancer following 30 Gy/10 f preoperative radiotherapy].
Wang L; Li Z; Li M; Peng Y; Gu J
Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Oct; 17(10):990-6. PubMed ID: 25341906
[TBL] [Abstract][Full Text] [Related]
13. Budding as a useful prognostic marker in pT3 well- or moderately-differentiated rectal adenocarcinoma.
Okuyama T; Oya M; Ishikawa H
J Surg Oncol; 2003 May; 83(1):42-7. PubMed ID: 12722096
[TBL] [Abstract][Full Text] [Related]
14. Tumor budding correlates with occult cervical lymph node metastasis and poor prognosis in clinical early-stage tongue squamous cell carcinoma.
Xie N; Wang C; Liu X; Li R; Hou J; Chen X; Huang H
J Oral Pathol Med; 2015 Apr; 44(4):266-72. PubMed ID: 25169851
[TBL] [Abstract][Full Text] [Related]
15. Tumor budding outperforms ypT and ypN classification in predicting outcome of rectal cancer after neoadjuvant chemoradiotherapy.
Trotsyuk I; Sparschuh H; Müller AJ; Neumann K; Kruschewski M; Horst D; Elezkurtaj S
BMC Cancer; 2019 Nov; 19(1):1033. PubMed ID: 31675950
[TBL] [Abstract][Full Text] [Related]
16. Tumor budding is an independent predictor of outcome in AJCC/UICC stage II colorectal cancer.
Betge J; Kornprat P; Pollheimer MJ; Lindtner RA; Schlemmer A; Rehak P; Vieth M; Langner C
Ann Surg Oncol; 2012 Nov; 19(12):3706-12. PubMed ID: 22669453
[TBL] [Abstract][Full Text] [Related]
17. [Safety and prognosis analysis of transanal total mesorectal excision versus laparoscopic mesorectal excision for mid-low rectal cancer].
Sun R; Cong L; Qiu HZ; Lin GL; Wu B; Niu BZ; Sun XY; Zhou JL; Xu L; Lu JY; Xiao Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jun; 25(6):522-530. PubMed ID: 35754217
[No Abstract] [Full Text] [Related]
18. The role of para-aortic lymphadenectomy in surgical management of patients with stage N+ rectal cancer below the peritoneal reflection.
Liu YL; Wang YH; Yang YM; Li MQ; Jiang SX; Wang XS
Cell Biochem Biophys; 2012 Jan; 62(1):41-6. PubMed ID: 21833674
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of clinical and pathological stages on locally advanced rectal carcinoma after neoadjuvant chemoradiotherapy.
Wen B; Zhang L; Wang C; Huang R; Peng H; Zhang T; Dong J; Xiao W; Zeng Z; Liu M; Gao Y
Radiat Oncol; 2015 Jun; 10():124. PubMed ID: 26040453
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Impact of Lymph Node Ratio in Patients Undergoing Preoperative Chemoradiotherapy Followed by Curative Resection for Locally Advanced Rectal Cancer.
Jung W; Kim K; Kim J; Shim SJ
In Vivo; 2020; 34(3):1247-1253. PubMed ID: 32354915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
